Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells

Clinical Cancer Research

Volumn 7, Issue 1, 2001, Pages 145-152

  Robey, Robert W ^a   Medina Peèrez, Wilma Y ^a   Nishiyama, Kenryu ^a   Lahusen, Tyler ^b   Miyake, Keisuke ^a   Litman, Thomas ^a   Senderowicz, Adrian M ^b   Ross, Douglas D ^c   Bates, Susan E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; CALCEIN; FLAVOPIRIDOL; FUMITREMORGIN C; GLYCOPROTEIN P; IRINOTECAN; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PROTEIN INHIBITOR; RHODAMINE 123; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DRUG RESISTANCE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INDOLES; MITOXANTRONE; MYCOTOXINS; NEOPLASM PROTEINS; P-GLYCOPROTEINS; PIPERIDINES; POLYMERASE CHAIN REACTION; RADIOPHARMACEUTICALS; TUMOR CELLS, CULTURED;

EID: 0035138482     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
2. Flavopiridol: The first cyclin-dependent kinase inhibitor in human clinical trials
3. Preclinical and clinical development of cyclin-dependent kinase modulators
4. Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol
5. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis
6. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines
7. Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells
8. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts
9. Flavopiridol: A cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells
10. Multidrug resistance: Molecular mechanisms and clinical relevance
11. The multidrug resistance protein family
12. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
13. A multidrug resistance transporter from human MCF-7 breast cancer cells
14. Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
15. Camptothecin resistance: Role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells
16. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
17. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
18. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein
19. Potent interaction of flavopiridol with MRP1
20. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
21. Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol
22. Breast cancer resistance protein (BCRP) associated drug export and p53 inactivation impact flavopiridol (FLA) antitumor activity
23. P-glycoprotein expression and schedule dependence of Adriamycin cytotoxicity in human colon carcinoma cell lines
24. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
25. P-glycoprotein mediates profound resistance to bisantrene
26. Characterization of Adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein
27. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance
28. New colorimetric cytotoxicity assay for anticancer-drug screening
29. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute Drug Screen
30. Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles
31. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: Quantitation by a validated polymerase chain reaction assay
32. 4 and structurally related conjugates
33. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein
34. P-glycoprotein substrates and antagonists cluster into two distinct groups
35. ABC transporters involved in transport of eye pigment precursors in Drosophila melanogaster
36. Novel splicing of the human MHC-encoded peptide transporter confers unique properties